3M CO Cash and Restricted Cash
3M CO (MMM) had Cash and Restricted Cash of $2.96 billion as of 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-21
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.96B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.73B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.24B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.67B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $2.96B 10-Q · filed 2026-07-21 |
| 2026-03-31 | $3.73B 10-Q · filed 2026-04-21 |
| 2025-12-31 | $5.24B 10-Q · filed 2026-07-21 |
| 2025-09-30 | $4.67B 10-Q · filed 2025-10-21 |
| 2025-06-30 | $3.71B 10-Q · filed 2026-07-21 |
| 2025-03-31 | $6.33B 10-Q · filed 2026-04-21 |
| 2024-12-31 | $5.60B 10-Q · filed 2026-07-21 |
| 2024-09-30 | $6.05B 10-Q · filed 2025-10-21 |
| 2024-06-30 | $10.08B 10-Q · filed 2025-07-18 |
| 2024-03-31 | $10.91B 10-Q · filed 2025-04-22 |
| 2023-12-31 | $5.93B 10-K · filed 2026-02-03 |
| 2023-09-30 | $5.14B 10-Q · filed 2024-10-22 |
| 2023-06-30 | $4.26B 10-Q · filed 2024-07-26 |
| 2023-03-31 | $3.82B 10-Q · filed 2024-04-30 |
| 2022-12-31 | $3.65B 10-K · filed 2026-02-03 |
| 2022-09-30 | $3.40B 10-Q · filed 2023-10-24 |
| 2022-06-30 | $2.72B 10-Q · filed 2023-07-25 |
| 2022-03-31 | $3.25B 10-Q · filed 2023-04-25 |
| 2021-12-31 | $4.56B 10-K · filed 2025-02-05 |
| 2020-12-31 | $4.63B 10-K · filed 2024-02-07 |
| 2019-09-30 | $7.73B 10-Q · filed 2019-10-25 |
| 2019-06-30 | $2.85B 10-Q · filed 2019-07-26 |
| 2019-03-31 | $2.94B 10-Q · filed 2019-04-26 |
| 2018-12-31 | $2.85B 10-Q · filed 2019-10-25 |
| 2018-09-30 | $3.19B 10-Q · filed 2019-10-25 |
| 2018-06-30 | $2.80B 10-Q · filed 2019-07-26 |
| 2018-03-31 | $3.49B 10-Q · filed 2019-04-26 |
| 2017-12-31 | $3.05B 10-Q · filed 2019-10-25 |
| 2017-09-30 | $2.83B 10-Q · filed 2018-10-25 |
| 2017-06-30 | $2.65B 10-Q · filed 2018-07-26 |
| 2017-03-31 | $2.17B 10-Q · filed 2018-05-08 |
| 2016-12-31 | $2.40B 10-K · filed 2019-02-07 |
| 2016-09-30 | $2.31B 10-Q · filed 2017-10-31 |
| 2016-06-30 | $1.69B 10-Q · filed 2017-08-01 |
| 2015-12-31 | $1.80B 10-K · filed 2019-02-07 |
| 2014-12-31 | $1.90B 8-K · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |